Cerebain Biotech

Cerebain Biotech, established in 2007 and based in Costa Mesa, California, is a biomedical company specializing in the development of treatments for Alzheimer's disease. Its primary focus is the creation and clinical development of a minimally invasive, implantable medical device that leverages the regenerative properties of the omentum, a layer of tissue that generates biological agents nourishing nerves and promoting growth. Additionally, Cerebain Biotech explores synthetic drug solutions to complement its medical device offerings.